elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q58564259-9FD66E0B-511A-4E95-A671-463929D3E0D8
Q58564259-9FD66E0B-511A-4E95-A671-463929D3E0D8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58564259-9FD66E0B-511A-4E95-A671-463929D3E0D8
Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models
P2860
Q58564259-9FD66E0B-511A-4E95-A671-463929D3E0D8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58564259-9FD66E0B-511A-4E95-A671-463929D3E0D8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
da3a48d7ea9b76b5161793990d77f641723da471
P2860
Cabozantinib Eradicates Advanced Murine Prostate Cancer by Activating Antitumor Innate Immunity.